Holen Sie sich die Stockscreener-App
6.58
4.22%
-0.29
Handel nachbörslich:
6.70
0.12
+1.82%
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
15.85%
67.18
|
57.99 | 50.08 | 45.88 | 47.86 |
| Operating Income/Loss |
15.85%
-67.18
|
-57.99 | -50.08 | -45.88 | -47.86 |
| Nonoperating Income/Loss |
18.75%
3.979
|
4.897 | 4.023 | 3.66 | 4.08 |
| Net Income/Loss |
19.05%
-63.20
|
-53.09 | -46.06 | -42.22 | -43.78 |
| Basic Average Shares |
1.61%
104.45
|
102.80 | - | 85.73 | 85.50 |
| Diluted Average Shares |
1.61%
104.45
|
102.80 | - | 85.73 | 85.50 |
| Basic Earnings Per Share |
17.31%
-0.61
|
-0.52 | - | -0.49 | -0.51 |
| Diluted Earnings Per Share |
17.31%
-0.61
|
-0.52 | - | -0.49 | -0.51 |
3.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):